From: Feasibility of up-regulating CD4+CD25+ Tregs by IFN-γ in myasthenia gravis patients
IFN-γ (ng/ml)
0
20
40
80
CD4+CD25+ (%)
32.8 ± 3.2**
55.2 ± 3.7*
54.1 ± 4.1*
42.8 ± 2.9*,**